FDA clears Zimmer Biomet’s robotic knee surgery system

knee x-ray
Zimmer Biomet acquired the Rosa system and dove into the robotic surgery space in 2016, with its purchase of French manufacturer Medtech in 2016 for about $132 million. (Pixabay)

Zimmer Biomet received a 510(k) clearance from the FDA for its robotic assistance platform for total knee replacement surgeries.

The Rosa knee system includes three-dimensional, preoperative planning tools, and provides data on soft-tissue and bone anatomy during the procedure to help improve cutting accuracy and implant alignment. It also performs real-time range-of-motion analyses to help balance soft tissue in the joint on a patient-specific basis.

"We are excited for the launch of Rosa Knee, which brings together Zimmer Biomet's robotics technology with our industry-leading knee implants to help surgeons personalize surgical procedures for their patients," Ivan Tornos, Zimmer Biomet’s group president of orthopedics, said in a statement.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The system uses the company's X-Atlas imaging protocol, using X-ray scans to build a 3D model and plan of a patient's bone anatomy. It also incorporates navigation tools from Zimmer Biomet’s larger Rosa Robotics platform, which includes brain- and spine-focused systems for neurosurgery.

RELATED: 2018 could see a robotic surgery shake-up

Zimmer Biomet acquired the Rosa system and dove into the robotic surgery space in 2016, with its purchase of French manufacturer Medtech for about $132 million.

Rosa Brain received an FDA clearance in 2012, and has been used to provide guidance in treatments for hydrocephalus, generalized dystonia, Parkinson’s disease and cavernoma. Meanwhile, Rosa Spine netted a CE mark in 2014 and an FDA clearance in 2016.

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its Star Trek-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.